Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa

Details for Australian Patent Application No. 2008216799 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Tuthill, Cynthia; Rios, Israel

Agent Wrays

Pub. Number AU-A-2008216799

PCT Pub. Number WO2008/100458

Priority 60/900,977 13.02.07 US

Filing date 11 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/100458 Priority application(s): WO2008/100458

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216804-3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2C adrenoreceptor agonists

2008216798-Functionally selective alpha2C adrenoreceptor agonists